Synthes reports merger talks with Johnson & Johnson

The deal could be worth up to $20bn and if completed would be one of the largest healthcare takeover in recent years, according to sources familiar with the process.

“No assurance can be given as to whether, when or on what terms any possible transaction might occur,” it added.
Synthes said it does not intend to make any further public statements unless and until a definitive agreement has been reached, or until discussions between the parties have terminated.

Print Friendly, PDF & Email
No tags for this post.

Related posts

Leave a Reply

Your email address will not be published. Required fields are marked *